首页> 外文期刊>Clinical nephrology >Long-term outcome of single pediatric donor kidney transplants between African-American and non-African-American adults.
【24h】

Long-term outcome of single pediatric donor kidney transplants between African-American and non-African-American adults.

机译:非裔美国成年人和非裔美国成年人之间单次小儿供体肾脏移植的长期结果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: African-American (AA) ethnicity has been considered a risk factor for graft loss after kidney transplant. The long-term graft survival of single pediatric donor kidney transplants in AA adults has not been reported. METHODS: We retrospectively compared the outcome of 43 AA and 32 non-African-American (NAA) adults transplanted with single pediatric kidneys from donors aged 10 years or less in our center. A combination of tacrolimus, mycophenolic acid and steroid was utilized as the maintenance therapy. RESULTS: Similar immunosuppressive dose and targeted level were achieved between the AA and the NAA groups. Median body weight (BW) of donors was 20 kg (8 - 36) in the AA group and 19 kg (8.5 - 35) in NAA group. There was no statistically significant difference in the incidence of rejection between the AA and NAA groups (26 vs. 16%, p = 0.45). The surgical complications, delayed graft function, and development of proteinuria and focal and segmental glomerulosclerosis (FSGS) were similar in both groups. The patient and graft survivals in the AA group were slightly higher compared to the NAA group. The death-censored analysis demonstrated no difference in graft survival between the AA and NAA groups (p = 0.90): 86 vs. 82% at 1 year, 70 vs. 71% at 3 years, and 62 vs. 64% at 5 years. CONCLUSIONS: Single pediatric donor kidney transplant in AA adults can be achieved with acceptable complications and equivalent long-term outcomes as in NAA adults in the era of potent immunosuppressive regimen.
机译:背景:非洲裔美国人(AA)种族已被认为是肾移植后移植物丢失的危险因素。尚未有关于AA成年个体单供体肾脏移植的长期移植存活率的报道。方法:我们回顾性比较了来自我们中心的年龄在10岁或以下的供体的43例AA和32例非美国黑人(NAA)成年人的单根小儿肾脏移植的结果。他克莫司,麦考酚酸和类固醇的组合被用作维持疗法。结果:AA和NAA组达到了相似的免疫抑制剂量和目标水平。 AA组的供体中值体重(BW)为20公斤(8-36),NAA组的为19公斤(8.5-35)。 AA组和NAA组之间的排斥发生率无统计学差异(26%vs. 16%,p = 0.45)。两组的手术并发症,移植物功能延迟,蛋白尿发展以及局灶性和节段性肾小球硬化症(FSGS)相似。与NAA组相比,AA组的患者和移植物存活率略高。死亡检查分析显示,AA和NAA组之间的移植物存活率没有差异(p = 0.90):1年时86%vs. 82%,3年时70%vs. 71%,以及5年时62 vs. 64% 。结论:在有效的免疫抑制方案时代,在AA成人中进行单次小儿供体肾脏移植可以达到可接受的并发症并具有与NAA成人相同的长期结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号